Antibody Response
The antibody (humoral) response is the arm of adaptive immunity in which B cells, with help from CD4+ T cells, produce antigen-specific antibodies that neutralize pathogens and toxins. For most licensed vaccines it is the dominant and most readily measured marker of immunogenicity, and antibody titres often serve as the correlate of protection on which vaccines are evaluated.
Definition
The antibody response is the production of antigen-specific immunoglobulins by B-lineage cells following exposure to an antigen, encompassing the primary response, affinity maturation and class switching in germinal centres, and the establishment of long-lived plasma cells that sustain circulating antibody.
Scope
The topic covers how antibodies are generated after antigen encounter, the germinal-centre reaction that produces high-affinity antibodies and long-lived plasma cells, the kinetics and durability of antibody responses, and the use of antibody titres as correlates of protection. It is a mechanistic and conceptual reference, not guidance on measuring or interpreting titres for individual patients.
Core questions
- How do B cells and helper T cells cooperate to generate high-affinity antibodies?
- What governs the magnitude and durability of an antibody response after vaccination?
- When does an antibody titre serve as a valid correlate of protection?
Key concepts
- Germinal-centre reaction
- Affinity maturation
- Class (isotype) switching
- Long-lived plasma cells
- Neutralizing antibodies
- Antibody titre as a correlate of protection
- Primary versus secondary (anamnestic) response
Mechanisms
After antigen is captured and presented, naive B cells that recognize the antigen receive help from follicular helper T cells and enter germinal centres, where they undergo somatic hypermutation and selection for higher affinity (affinity maturation) and switch immunoglobulin class. The output is high-affinity memory B cells and long-lived plasma cells that home to the bone marrow and secrete antibody for years, sustaining the circulating titre that Amanna and colleagues showed can persist for decades. Antibodies protect by neutralizing pathogens or toxins, opsonizing them for phagocytosis, and activating complement; Plotkin's analyses show that for many vaccines a defined antibody threshold predicts protection.
Clinical relevance
Antibody titres are the immunogenicity readout most often used to license and monitor vaccines, and understanding the humoral response clarifies why some titres predict protection while others do not, and why responses wane. This entry explains how the antibody response is generated and interpreted at the level of mechanism and evidence; it is not a basis for ordering or acting on serologic tests in individual care.
Epidemiology
For diphtheria, tetanus, hepatitis B, measles and several other vaccines, population studies have established antibody thresholds associated with protection, allowing serosurveys to estimate population immunity and allowing new vaccines to be bridged to protection on immunogenicity data. The durability of these antibody responses, documented in long-term cohorts, shapes booster policy.
History
The humoral theory of immunity dates to the discovery of antitoxins in the 1890s, and antibody titration became the earliest quantitative tool of immunology. The germinal-centre basis of affinity maturation and the recognition of long-lived plasma cells as the source of durable antibody were clarified in the late twentieth and early twenty-first centuries, integrating the cellular machinery behind the antibody response with its protective role in vaccination.
Debates
- Are antibody titres sufficient as correlates of protection?
- For many vaccines a serum antibody threshold predicts protection, but for others protection depends on antibody quality (avidity, function), mucosal antibody, or cellular immunity, so a single titre may under- or over-estimate true protection.
Key figures
- Gabriel Victora
- Michel Nussenzweig
- Mark Slifka
- Stanley Plotkin
Related topics
Seminal works
- victora-nussenzweig-2012
- amanna-2007
- plotkin-2010
Frequently asked questions
- What does a higher antibody titre mean after vaccination?
- A higher titre indicates a stronger humoral response, and for vaccines with an established correlate of protection a titre above a defined threshold is associated with protection. However, titre alone does not capture antibody function or cellular immunity, so it is an indicator rather than a complete measure of protection.
- Why do antibody levels fall over time?
- After the initial response, antibody is sustained mainly by long-lived plasma cells, and circulating levels decline as antigen is cleared and these cell populations contract. The rate of waning varies by vaccine and antigen, which is why some vaccines need boosters and others give long-lasting antibody.